This course has expired. View available courses.
Respirology
Setting the facts straight around triple therapy in COPD
Evidence-based treatment guidelines, including the Canadian Thoracic Society’s 2019 guideline, clearly define the place of triple inhaled therapy in the management of chronic obstructive pulmonary disease (COPD). However, clinicians may have inadequate knowledge about some aspects of COPD management, and may harbour misconceptions, including about the role of triple therapy versus dual inhaled therapy in COPD, treatment selection for COPD according to the patient, differences between various COPD inhaler devices, and the safety profiles of inhaled corticosteroids (ICS) used in COPD. This educational program discusses these aspects of triple therapy in COPD and addresses prevailing myths/misconceptions.
The program is composed of four vignettes:
- Vignette 1: Disease burden and approach to management
- Vignette 2: Triple therapy for COPD: the evidence
- Vignette 3: Selecting the right inhaler for the patient
- Vignette 4: ICS Risks and benefits in COPD
The vignettes cover available data and current recommendations for COPD management, and also include interactive patient case studies, to provide clinicians with a comprehensive update on this topic.
DURATION
1 hour
PROFESSION
Physician
# OF CREDITS
1
ACCREDITATION
Mainpro+
EXPIRY DATE
2021-02-25
Evidence-based treatment guidelines, including the Canadian Thoracic Society’s 2019 guideline, clearly define the place of triple inhaled therapy in the management of chronic obstructive pulmonary disease (COPD). However, clinicians may have inadequate knowledge about some aspects of COPD management, and may harbour misconceptions, including about the role of triple therapy versus dual inhaled therapy in COPD, treatment selection for COPD according to the patient, differences between various COPD inhaler devices, and the safety profiles of inhaled corticosteroids (ICS) used in COPD. This educational program discusses these aspects of triple therapy in COPD and addresses prevailing myths/misconceptions.
The program is composed of four vignettes:
- Vignette 1: Disease burden and approach to management
- Vignette 2: Triple therapy for COPD: the evidence
- Vignette 3: Selecting the right inhaler for the patient
- Vignette 4: ICS Risks and benefits in COPD
The vignettes cover available data and current recommendations for COPD management, and also include interactive patient case studies, to provide clinicians with a comprehensive update on this topic.
Faculty
- Charles K.N. Chan MD, FRCPC, FCCP, FACP
- Gordon Dyck, MD, MCFP, BSc(Med), BA
- Suzanne Levitz, M.D.,C.M., CCFP
- Jonathan Peck, MD, CCFP
Learning objectives
On completion of this program, participants should be able to:
- Describe the place of triple inhaled therapy versus dual bronchodilators in the management of chronic obstructive pulmonary disease (COPD), and how treatable traits (symptoms vs exacerbations) should drive the choice of treatment
- Discuss the selection of inhaled drug therapy for COPD according to the patient
- Describe the differences in ease of use, minimum inspiratory flow requirements and peak inspiratory flow requirements for various COPD inhaler types
- Discuss the safety profile of inhaled corticosteroids in triple combination regimens for COPD
Accreditation
# of credits: 1
Duration: 1 hour
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
